lymphoma

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

lymphoma
Sep 13, 2024, 23:49 | Blog
Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting
Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…
Sep 13, 2024, 14:17 | Opinion
Sendurai Mani: A walk to bring awareness for Cancer and early detection to save lives
Sendurai Mani shared on Linkedin: ''On September 7th, 2024, in honor of cancer survivors, to…
Sep 10, 2024, 13:56 | Blog
Aren Karapetyan: I highlighted my poster presentation on Patterns of Radiotherapy for Lymphoma in Armenia at SOHO 2024
Aren Karapetyan, Medical Resident at Yerevan State Medical University named after Mkhitar Heratsi and Secretary…
Sep 7, 2024, 10:11 | Insight
Cancer-Related Fatigue in Patients and Survivors of Lymphoma by Steve Kalloger et al.
AACR Journals shared on LinkedIn: “Cancer-related fatigue is often underreported and poorly understood. Check out…
Sep 5, 2024, 05:09 | Blog
Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024
Joshua Brody shared on LinkedIn: "Excited for the Amps-to-go-up-to-11 at tomorrow's CME event on CAR…
Sep 4, 2024, 15:50 | Blog
Shreevikaa Kannan: The challenges of CAR-T therapies in T-cell lymphoma by Jasmine Zain
Shreevikaa Kannan, Head of TSMU academic department, shared on LinkedIn: "Don't miss the opportunity to hear…
Aug 27, 2024, 22:40 | Insight
Raul Cordoba: CART cell therapy is a feasible treatment option for older patients with lymphoma
Raul Cordoba shared a paper by Rebeca Bailén et al. on X: "CART cell therapy…
Aug 27, 2024, 13:04 | Blog
August 26 is the International Dog Day!
August 26 is International Dog Day, a time to celebrate the joy, loyalty, and companionship…
Aug 25, 2024, 16:05 | Insight
Kimryn Rathmell: ViPOR regimen is helping more B-cell lymphoma patients achieve full remission
Kimryn Rathmell shared a post on X: "A new NCI study shows the ViPOR regimen,…
Aug 23, 2024, 06:22 | Blog
Highlights from the 2024 Seattle Cellular Therapy Summit
The 2024 Seattle Cellular Therapy Summit will feature leading experts who will provide a detailed…
Aug 20, 2024, 14:29 | Blog
Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?
Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…
Aug 15, 2024, 04:56 | Blog
Hung Trinh: A novel CAR-Enhancer to prevent relapse after CAR-T Therapy by Dana-Farber Cancer Institute
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Aug 12, 2024, 13:10 | Insight
Matt Wilson: Updated good practice paper on CNS prophylaxis in LBCL
Matt Wilson, Consultant Haematomogist specialising in lymphoma at The Beatson West of Scotland Cancer Centre,…
Aug 9, 2024, 10:21 | Insight
Immunotherapy with chemo improves survival for aggressive relapsed lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at…
Aug 9, 2024, 05:13 | Insight
Krishna Komanduri: CMV reactivation after CAR-T therapy for lymphoma
Recently, an article by Rick Lin et al. titled "Incidence and outcomes of cytomegalovirus reactivation…
Aug 5, 2024, 11:50 | Blog
Annals of Research in Oncology - Case study on extranodal non-Hodgkin B-cell marginal zone lymphoma
Annals of Research in Oncology shared on LinkedIn: "New case study on Lymphoma in Parotid Gland…
Aug 4, 2024, 09:41 | Insight
Michael Jain: 5-year outcomes of standard-of-care Axicabtagene Ciloleucel in lymphoma patients
Michael Jain, Oncologist at Moffitt Cancer Center, shared on X: "What is important for long-term…
Jul 28, 2024, 12:41 | Blog
Mohamed Kharfan-Dabaja: Great overview on management of indolent lymphomas by Urshila Durani
Mohamed Kharfan-Dabaja, Vice Chair of Hematology at Mayo Clinic Comprehensive Cancer Center, shared a post…
Jul 26, 2024, 19:54 | Career
Juan Rangel: I’m officially a Lymphoma/ASCT doctor after my fellowship at Princess Margaret Hospital
Juan Rangel, Lymphoma/ASCT doctor at Princess Margaret Hospital, shared on X: "I’m officially a Lymphoma/ASCT…
Jul 24, 2024, 08:12 | Insight
Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma
Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…
Jul 22, 2024, 14:33 | Career
Sharon Castellino has been appointed to the board of directors of The Leukemia and Lymphoma Society - Winship Cancer Institute
Winship Cancer Institute of Emory University shared a post on LinkedIn: "Winship pediatric hematologist Sharon…
Jul 21, 2024, 11:37 | Blog
Ruben Mesa: ASCO overview of advances in lymphoma
Ruben Mesa shared on LinkedIn: "Our amazing Chair of Hematology and world expert in lymphoma Nilanjan…
Jul 18, 2024, 00:18 | Insight
Joshua Brody: Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared on…
Jul 15, 2024, 21:23 | Insight
Jason Yongsheng Chan: Cancer Discovery Hub's collaboration with Illumina focusing on Asian lymphomas occuring in younger patients
Jason Yongsheng Chan, Platform Lead at Singapore Translational Cancer Consortium, shared a post by Mynn…
Jul 13, 2024, 09:41 | Insight
IMMONC - Immune Oncology Research Institute's Experience in Advancing Clinical Cancer Research in Armenia
Cancer affects people across the world regardless of their socioeconomic status. However, low- and middle-income…
Jul 12, 2024, 21:49 | Blog
Q&A with Sarcoma Researcher and Oncologist Gina D’Amato - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on LinkedIn: "Dr. Gina D’Amato is medical oncologist treating sarcoma at…
Jul 10, 2024, 06:37 | Insight
Paul Bröckelmann: You don't see a study on Hodgkin Lymphoma published in Science Magazine everyday
Paul Bröckelmann, Physician Scientist at MPI for Biology of Ageing, shared on X: "You don't…
Jul 8, 2024, 17:31 | Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Jun 19, 2024, 22:16 | Blog
Michael Wang: An international randomized phase 3 trial is a huge undertaking
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Jun 19, 2024, 12:19 | Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Jun 19, 2024, 06:53 | Insight
Raul Cordoba: Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma
Raul Cordoba shared on X: "HOT OFF THE PRESS! Epcoritamab monotherapy in patients with relapsed…
Jun 19, 2024, 01:26 | Blog
Ami Patel: An honor to work with Naveen Pemmaraju on MPN review article
Ami Patel, Hematologist at Huntsman Cancer Institute, shared a post by Naveen Pemmaraju on X, adding: “An…
Jun 18, 2024, 16:51 | Blog
Raul Cordoba: Very happy to provide mentorship to Young EHA members
Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, Madrid,…
Jun 18, 2024, 10:27 | Insight
Naveen Pemmaraju: Our brand new MPN state-of-the-art review paper
Naveen Pemmaraju shared on LinkedIn:         . "Super excited to share our brand…
Jun 18, 2024, 04:43 | Blog
Ruben Mesa: Wonderful work by Nilanjan Ghosh at EHA2024
Ruben Mesa shared a post by Nilanjan Ghosh, Chair of Department of Hematologic Oncology and…
Jun 16, 2024, 14:53 | Blog
Dr. Kami Maddocks is a OSUCCC – James Cancer Hospital Excellence Award winner - OSU Hematology
OSU Hematology recently shared a post on X: "Last month, the OSUCCC – James Cancer…
Jun 14, 2024, 13:42 | Blog
Ruben Mesa: Dr Nilanjan Ghosh raising over $300,000 at The Leukemia and Lymphoma Society 'Visionary of the Year'
Ruben Mesa shared on LinkedIn:                . "So proud…
Jun 13, 2024, 06:51 | Insight
Racial disparities among patients treated with CART-cell therapy for lymphoma - Penn Medicine
Penn Medicine shared a post on X:  “A new NEJM Evidence study found racial disparities…
Jun 11, 2024, 14:59 | Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
May 28, 2024, 06:38 | Blog
Soon Thye Lim: It’s not every day that you get news that your research team will be awarded S$25 million
Soon Thye Lim, Chief Executive Officer at National Cancer Centre Singapore, shared a post on LinkedIn: "It’s…
May 28, 2024, 00:56 | Insight
Pallawi Torka: Excited to attend ASCO24 next week and represent Memorial Sloan Kettering Cancer
Pallawi Torka, Assistant Attending at Memorial Sloan Kettering Cancer, shared a post on X: “Excited…
May 26, 2024, 11:34 | Insight
Krishna Komanduri: Congrats to Sattva Neelapu and colleagues for this correlative study on CAR-T cell fitness and function in lymphoma
Krishna Komanduri, Physician-in-Chief at the Helen Diller Family Comprehensive Cancer Center, shared a post by…
May 26, 2024, 01:41 | Blog
Institute of Molecular and Cell Biology part of two recently awarded NRF OF-LCG projects led by National Cancer Centre Singapore
Institute of Molecular and Cell Biology shared a post on LinkedIn: "Making an impact on patients'…
May 25, 2024, 13:26 | Societies
MD Anderson Cancer Center researchers will showcase the latest breakthroughs in cancer care at the 2024 ASCO Annual Meeting
MD Anderson Cancer Center shared on LinkedIn: "MD Anderson researchers will showcase the latest breakthroughs…
May 24, 2024, 13:11 | Blog
Kelley Wood: We observed significant improvements in Quality of Life across 12 different cancer types
Kelley Wood, Research Director at ReVital Cancer Rehab, made the following post on LinkedIn: “NEW PUB…
May 21, 2024, 12:00 | Blog
Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
May 20, 2024, 15:34 | Blog
Alessandra Curioni Fontecedro: Gaëlle Rhyner is a fantastic colleague fully dedicated to patients and head of Lymphoma group
Alessandra Curioni Fontecedro, Head of Medical Oncology at the HFR Fribourg – Cantonal Hospital, shared…
May 18, 2024, 04:46 | Blog
Douglas Flora: Wonderful start to the day at The Leukemia and amp; Lymphoma Society’s Light The Night executive breakfast
Quoting Douglas Flora’s post on LinkedIn: “Had a wonderful start to the day at The Leukemia…
May 16, 2024, 14:09 | Societies
Join European School of Oncology’s webinar, ‘An Update: The Best of ASH in Lymphomas’
European School of Oncology shared on LinkedIn:  “Exciting News! Join us for today's webinar: ‘An…
May 15, 2024, 12:22 | Blog
The Babak Lab - Exciting Progress in Melanoma Treatment: Personalized Vaccines Show Promise
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 11, 2024, 13:57 | Blog
Michelle Tucker’s inspiring story of becoming a nurse - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "Michelle Tucker, BSN, RN, (right) wanted to be a nurse…
Apr 29, 2024, 00:16 | Insight
Kate Cwynarski: Wonderful talk by Philippe Gaulard
Kate Cwynarski, Haematogist-Oncologist in Lymphoma and CLL at University College London Hospital, shared on X/Twitter:…
Apr 25, 2024, 20:01 | Blog
Naveen Pemmaraju: Serious meeting of the heme minds today with Prof. Naveen Pemmaraju and Prof. Jason Westin
Naveen Pemmaraju shared on X: "Co-fellows to Co-Professors together at MD Anderson Cancer Center! Serious…
Apr 22, 2024, 01:02 | Career
Christopher Strouse Received the 2023 Donald D. Dorfman Award for lymphoma research - Internal Medicine at Iowa
Internal Medicine at Iowa shared on X/Twitter: "Clinical Assistant Professor of Internal Medicine Christopher Strouse,…
Apr 9, 2024, 17:56 | Insight
Myeloma Paper of the Day - Robert Z. Orlowski
Robert Z. Orlowski, Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma…
Apr 9, 2024, 17:16 | Positive
Raul Cordoba: Spent great times working with Mandy Lauw
Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, shared…
Apr 8, 2024, 08:41 | Insight
Elizabeth Budde: We reported the longest follow-up of using BsAbs in lymphoma
Elizabeth Budde, Associate Professor at City of Hope, shared on X/Twitter: "We reported the longest…
Apr 2, 2024, 05:25 | Blog
Marco Davila: Had a great time hosting Michael Jain to give a powerhouse Medicine Grand Rounds at Roswell Park
Marco Davila, SVP and Associate Cancer Center Director of Translational Research at Roswell Park Comprehensive…
Mar 31, 2024, 23:13 | Blog
Sanam Loghavi: Thrilled to be represented by the best partner in editing
Sanam Loghavi, Associate Professor of Pathology and Laboratory Medicine at the Department of Hematopathology at…
Mar 31, 2024, 23:07 | Blog
Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
Jan 18, 2024, 15:38 | Blog
Yumeng Zhang: Moffitt Cutaneous Lymphoma Rack Card has arrived
Yumeng Zhang, Lymphoma Researcher and Clinician at Moffitt Cancer Center, shared on X/Twitter: “Moffitt Cutaneous…
Jan 9, 2024, 18:48 | Blog
Nico Gagelmann: Gastrointestinal (GI) manifestations in hematology
Nico Gagelmann, Co-Chair for the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee, shared…
Jan 9, 2024, 18:38 | Blog
Samantha Siegel: NEVER HUSTLE BACKWARDS, ALWAYS FORWARD
Samantha Siegel, a primary care doctor, cancer survivor and advocate, shared on LinkedIn: “Cancer Survivorship:…
Jan 3, 2024, 18:41 | Insight
Julie Vose: The long awaited publication from the NAMCL Project
Julie Vose shared a post on X/Twitter: ''Finally! The long awaited publication from the NAMCL Project!…
Dec 27, 2023, 17:10 | Blog
Julie Vose: She is a trooper and now sporting new hair and wearing lipstick!
Julie Vose shared a post by Nebraska Medicine on X/Twitter: "What a courageous strong woman!…
Oct 31, 2023, 23:19 | Blog
Bita Fakhri: Loved hearing these brilliant women in lymphoma openly sharing their career paths
Bita Fakhri, Hematologist and Oncologist at the Stanford Department of Medicine made the following post…
Oct 31, 2023, 10:22 | Insight
5 Decades of Impact reflection series - Australasian Leukaemia and Lymphoma Group
Australasian Leukaemia and Lymphoma Group (ALLG) shared on their LinkedIn: "To mark the start of…
Oct 18, 2023, 16:52 | Career
Ginna Laport: I joined CARGO Therapeutics as their Chief Medical Officer
Ginna Laport, Chief Medical Officer at CARGO Therapeutics, shared a post by CARGO Therapeutics on…
Oct 4, 2023, 17:41 | Insight
Elie G. Dib: Huge shout-out to Dr. Brad Zebrack for spearheading this innovative research exemplifying the future of survivorship science!
Quoting Elie G. Dib, Associate Director of The Haematology Oncology training program at Saint Joseph…
Aug 17, 2023, 16:33 | Blog
Amer Zeidan: It has been 16 years and 300 papers since my first paper was published in July 2007.
Amer Zeidan wrote in a recent tweet: ''It has been 16 years and 300 papers…
Aug 12, 2023, 16:19 | Drugs
Aaron Goodman: LOTIS-9 Trial in diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities
In a post on Twitter by Aaron Goodman, Hematologist/Bone Marrow Transplanter at UCSD, it says,…
Aug 8, 2023, 05:07 | Blog
Sometimes in cancer, watchful waiting wins! - Dima Abla
Sometimes in cancer, watchful waiting wins! A new publication titled: Spontaneous remission of angioimmunoblastic T-cell…
Aug 6, 2023, 18:39 | Blog
Are you an early-stage scientist or clinician with an interest in paediatric and young adult non Hodgkin lymphoma? - Emily James
Are you an early-stage scientist or clinician with an interest in paediatric and young adult…
Jul 28, 2023, 20:23 | Drugs
What to do with Rituximab intolerant patients? - Timothy Voorhees
What to do with Rituximab intolerant patients? Don’t drop CD20 Ab therapy, switch to Obinutuzumab…
Jul 20, 2023, 17:15 | Blog
The scarcity of approvals in brain & head & neck - Jean-Charles Soria
FDA oncology approvals by disease site since 2000 illustrates ❶ the high number of approvals…
Jul 7, 2023, 06:00 | Career
Ann S. LaCasce, MD, MMSc (Dana-Farber) as Chair of LRF’s Scientific Advisory Board - Lymphoma Research Foundation
We're proud to welcome Ann S. LaCasce, MD, MMSc (Dana-Farber) as Chair of LRF’s Scientific…
Jul 4, 2023, 16:50 | Insight
Targeting CCR7-PI3Ky overcomes resistance to tyrosine kinase inhibitors AKL-rearranged lymphoma - Marco Campisi
I am happy to share that one of my collaborative efforts is finally out in…
Jun 30, 2023, 18:19 | Positive
She’s a great example of what it means to survive and thrive - E. Anders Kolb
Throughout June, in commemoration of National Cancer Survivor Month, we at The Leukemia & Lymphoma Society have…
Jun 18, 2023, 16:32 | Drugs
FDA approved our new bispecific antibody for treating people with relapsed or refractory Diffuse Large B-cell Lymphoma
In a post by Alexander Hardy on Linkedin, it says, "I’m excited to share that…
Jun 16, 2023, 18:25 | Stories
Tracked roots of Sir Thomas Hodgkin
In a post by Gaurav Prakash on Twitter, it says, “A kind of pilgrimage for…
May 14, 2023, 13:48 | Positive
Fund Raising at Bear Necessities Pediatric Cancer Foundation
WALKER'S BEAR HUG Walker is 9 years old and in treatment for Lymphoma. Walker LOVES…
All: 81 Posts: 1 - 100
Special Coverage